T. Rowe Price Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-209,418
Closed -$186K 2992
2022
Q4
$186K Buy
209,418
+16,181
+8% +$14.4K ﹤0.01% 2553
2022
Q3
$304K Buy
193,237
+51,676
+37% +$81.3K ﹤0.01% 2375
2022
Q2
$285K Buy
141,561
+10,846
+8% +$21.8K ﹤0.01% 2457
2022
Q1
$305K Buy
130,715
+18,809
+17% +$43.9K ﹤0.01% 2535
2021
Q4
$520K Buy
111,906
+9,933
+10% +$46.2K ﹤0.01% 2370
2021
Q3
$778K Sell
101,973
-22,500
-18% -$172K ﹤0.01% 2164
2021
Q2
$1.21M Buy
124,473
+13,989
+13% +$136K ﹤0.01% 1986
2021
Q1
$914K Sell
110,484
-7,891
-7% -$65.3K ﹤0.01% 2095
2020
Q4
$808K Buy
118,375
+4,222
+4% +$28.8K ﹤0.01% 2037
2020
Q3
$1.27M Buy
114,153
+41,607
+57% +$464K ﹤0.01% 1704
2020
Q2
$456K Sell
72,546
-3,643
-5% -$22.9K ﹤0.01% 2084
2020
Q1
$140K Buy
76,189
+32,000
+72% +$58.8K ﹤0.01% 2368
2019
Q4
$149K Buy
44,189
+4,864
+12% +$16.4K ﹤0.01% 2424
2019
Q3
$84K Buy
39,325
+953
+2% +$2.04K ﹤0.01% 2456
2019
Q2
$102K Buy
38,372
+25,200
+191% +$67K ﹤0.01% 2468
2019
Q1
$63K Buy
13,172
+400
+3% +$1.91K ﹤0.01% 2486
2018
Q4
$31K Sell
12,772
-60,454
-83% -$147K ﹤0.01% 2527
2018
Q3
$322K Buy
73,226
+24,653
+51% +$108K ﹤0.01% 2322
2018
Q2
$350K Buy
48,573
+3,877
+9% +$27.9K ﹤0.01% 2288
2018
Q1
$230K Sell
44,696
-32,604
-42% -$168K ﹤0.01% 2361
2017
Q4
$294K Buy
+77,300
New +$294K ﹤0.01% 2273
2015
Q4
Sell
-30,462
Closed -$256K 2548
2015
Q3
$256K Buy
+30,462
New +$256K ﹤0.01% 2197